The Salesforce-backed banking platform developer has filed for a $100m initial public offering having raised $80m late last year.

The IoT security technology provider had raised $48m in funding from investors including Qualcomm and Čez pre-acquisition.

Equifax was among the investors that provided $14.7m for the utility customer data provider to push its total funding past the $40m mark.

MemorialCare Innovation Fund contributed to a series D round that brought the heart valve technology developer's overall funding to more than $36m.

MemorialCare Innovation Fund contributed to a series D round that brought the Caltech spinout's overall funding to more than $36m.

Hartford Healthcare returned for a $50m series C round that will support the Stanford spinout in advancing potential treatments for severe liver and inflammatory bowel diseases.

The Qiagen-founded precision cancer technology provider agreed to an acquisition by Invitae sized at at least $325m in cash and shares currently valued at about $820m.

Main Sequence Ventures has returned for a $10m series B round that will drive Kasada's expansion efforts following its opening of headquarters in the US.

Novartis is the second largest investor in the gene therapy developer, which has filed to go public less than a year after closing a $150m round.

The series C round consisted of $77m in equity funding and $25m in venture debt, with Kaiser Permanente among the participants.